Search results for "(trans)dermal drug delivery"

showing 2 items of 2 documents

Valence Topological Charge-Transfer Indices for Dipole Moments

2003

Valence topological charge-transfer (CT) indices are applied to the calculation of dipole moments. The dipole moments calculated by algebraic and vector semisums of the CT indices are defined. The combination of the CT indices allows the estimation of the dipole moments. The model is generalized for molecules with heteroatoms. The ability of the indices for the description of the molecular charge distribution is established by comparing them with the dipole moment of the valence-isoelectronic series of benzene and styrene. Two CT indices, μ v e c (vector semisum of vertex-pair dipole moments) and μ V v e c (valence μ v e c ) are proposed. μ v e c and μ V v e c are important for the predicti…

Protein ConformationHeteroatomPharmaceutical ScienceBiochemistryAnalytical ChemistryElectricityComputational chemistryDrug DiscoveryPhysicsvalence topological charge-transfer indexChemistryCharge densityGeneral Medicinemolecular charge distributionCondensed Matter Physicstransdermal drug deliveryChemistry (miscellaneous)Molecular MedicineAtomic physicsInformation SystemsSteric effectsBond dipole momentStatic ElectricityTransition dipole momentBiophysicsElectronsFractal dimensionMolecular physicsBiophysical PhenomenaArticleCatalysislcsh:QD241-441Inorganic Chemistrylcsh:Organic chemistryAtomic orbitalMoleculePhysical and Theoretical ChemistryMolecular BiologyStyreneTopological quantum numberDipole momentModels StatisticalValence (chemistry)Chemical polarityOrganic ChemistryBenzeneModels Theoreticalvalence topological chargetransfer indexElectric dipole momentDipolephenyl alcoholModels ChemicalMoment (physics)Electric dipole transitionMolecules
researchProduct

Transdermal and Skin-Targeted Drug Delivery

1997

Background: The application of therapeutic agents to the skin addresses three general objectives: (a) the treatment of a variety of dermatologic diseases; (b) the “targeted” delivery of drugs to deeper subcutaneous tissues, with a concomitant reduction in systemic exposure; and (c) socalled transdermal administration to elicit a systemic pharmacologic effect. Objective: Recently, significant progress towards all three goals has been recorded and the level of research and development activity remains high. We aim to discuss these advances from mechanistic and clinical standpoints. Results: For the topical treatment of skin disease, novel vehicles (e.g., stabilized, supersaturated systems and…

SonophoresisDermatologyPharmacology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineSmall peptideTransdermal drug deliveryMedicineChemical penetration enhancersTransdermalddc:615LiposomeIontophoresisbusiness.industryIontophoresisControlled releasePatch technologyBioavailabilityElectroporationTargeted drug delivery030220 oncology & carcinogenesisLiposomesDrug deliverySurgerybusinessJournal of Cutaneous Medicine and Surgery
researchProduct